Copperwynd Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Copperwynd Financial, LLC

$361 Million
Q4 2024

A detailed history of Copperwynd Financial, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Copperwynd Financial, LLC holds 720 shares of REGN stock, worth $506,001. This represents 0.14% of its overall portfolio holdings.

Number of Shares

720

Previous 798 9.77%

Holding current value

$506,001

Previous $838,000 38.9%

% of portfolio

0.14%

Previous 0.25%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	SELL	$701.85 - $1046.91 $54,744 - $81,658	-78 Reduced 9.77%	720 $512,000
Q3 2024 Nov 04, 2024	BUY	$1024.09 - $1201.76 $10,240 - $12,017	10 Added 1.27%	798 $838,000
Q2 2024 Aug 15, 2024	BUY	$883.2 - $1071.19 $30,912 - $37,491	35 Added 4.65%	788 $828,000
Q1 2024 Apr 30, 2024	SELL	$902.69 - $993.35 $10,832 - $11,920	-12 Reduced 1.57%	753 $724,000
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $20,929 - $23,805	-27 Reduced 3.41%	765 $671,000
Q3 2023 Nov 07, 2023	SELL	$692.45 - $844.37 $19,388 - $23,642	-28 Reduced 3.41%	792 $651,000
Q2 2023 Aug 08, 2023	SELL	$700.03 - $830.35 $1,400 - $1,660	-2 Reduced 0.24%	820 $589,000
Q1 2023 Apr 28, 2023	BUY	$680.49 - $826.97 $8,165 - $9,923	12 Added 1.48%	822 $675,000
Q4 2022 Feb 02, 2023	SELL	$705.89 - $766.39 $9,882 - $10,729	-14 Reduced 1.7%	810 $584,000
Q3 2022 Nov 10, 2022	SELL	$573.97 - $724.32 $21,810 - $27,524	-38 Reduced 4.41%	824 $568,000
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $6,580 - $8,866	-12 Reduced 1.37%	862 $510,000
Q1 2022 Apr 21, 2022	BUY	$595.12 - $698.43 $99,980 - $117,336	168 Added 23.8%	874 $610,000
Q4 2021 Feb 04, 2022	BUY	$543.48 - $670.97 $1,086 - $1,341	2 Added 0.28%	706 $446,000
Q3 2021 Nov 03, 2021	BUY	$574.03 - $680.96 $404,117 - $479,395	704 New	704 $426,000
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $434,976 - $513,856	-920 Closed	0 $0
Q1 2021 May 06, 2021	BUY	$446.73 - $548.2 $133,125 - $163,363	298 Added 47.91%	920 $435,000
Q4 2020 Feb 10, 2021	BUY	$478.3 - $607.98 $71,266 - $90,589	149 Added 31.5%	622 $300,000
Q3 2020 Nov 05, 2020	BUY	$544.75 - $658.21 $59,922 - $72,403	110 Added 30.3%	473 $265,000
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $179,075 - $233,742	363 New	363 $226,000

Others Institutions Holding REGN

# of Institutions

1,490

Shares Held

85.7M

Call Options Held

1.53M

Put Options Held

1.44M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Copperwynd Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Copperwynd Financial, LLC with notifications on news.

Account

Copperwynd Financial, LLC Regeneron Pharmaceuticals, Inc. Transaction History